Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Yahoo/Fly on the Wall
Fri, 10/4/13 - 12:40 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
3 Key Points From Sarepta's Eteplirsen Study Update (And They're Positive)
TheStreet.com
Thu, 09/26/13 - 10:35 am
Sarepta
eteplirsen
Genentech
GSK
Duchenne Muscular Dystrophy
Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly
Seeking Alpha
Mon, 09/23/13 - 10:37 am
Prosensa
Sarepta Therapeutics
drisapersen
GSK
Duchenne Muscular Dystrophy
The Good, the Bad, and the Ugly of a Competitor's Failure
Motley Fool
Sat, 09/21/13 - 10:11 am
GSK
Prosensa
Duchenne Muscular Dystrophy
muscular dystrophy
eteplirsen
Sarepta Therapeutics
GSK, Prosensa muscular dystrophy drug misses study goal
Reuters
Fri, 09/20/13 - 09:36 am
GSK
Prosensa
drisapersen
Duchenne Muscular Dystrophy
Sarepta shares jump after disappointing test for rival drug
Reuters
Fri, 08/16/13 - 10:33 am
Prosensa
drisapersen
Duchenne Muscular Dystrophy
GSK
Sarepta
eteplirsen
Potential Paradigm Shifting Technology from a Small Biotech
Motley Fool
Sat, 08/3/13 - 10:36 am
Sarepta Therapeutics
eteplirsen
muscular dystrophy
Duchenne Muscular Dystrophy
Sarepta To Seek Early U.S. Approval For Muscular Dystrophy Drug
TheStreet.com
Wed, 07/24/13 - 09:54 am
Sarepta
FDA
Duchenne Muscular Dystrophy
eteplirsen
Is The DMD Market Becoming Too Crowded?
Motley Fool
Tue, 07/9/13 - 05:14 pm
Duchenne Muscular Dystrophy
Sarepta
eteplirsen
drisapersen
GSK
PTC Therapeutics
Glaxo grabs coveted breakthrough drug status for muscular dystrophy drug
Fierce Biotech
Thu, 06/27/13 - 11:56 am
breakthrough therapies
GSK
drisapersen
Duchenne Muscular Dystrophy
Sarepta And Eteplirsen: Will 12 Patients Be Enough For The FDA?
Seeking Alpha
Wed, 06/19/13 - 10:33 am
Sarepta
eteplirsen
FDA
GSK
Duchenne Muscular Dystrophy
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Thu, 04/25/13 - 09:24 am
Sarepta
GSK
eteplirsen
Duchenne Muscular Dystrophy
2 Views on Sarepta's FDA News
Motley Fool
Tue, 04/16/13 - 12:02 pm
FDA
Duchenne Muscular Dystrophy
Sarepta
eteplirsen
Sarepta tumbles after FDA requests more data on drug
The Fly on the Wall
Tue, 04/16/13 - 10:49 am
FDA
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Fans: A Single Data Slide Raises Questions About Glaxo's DMD Drug
TheStreet.com
Fri, 04/12/13 - 01:28 pm
Sarepta
GSK
Duchenne Muscular Dystrophy
drisapersen
eteplirsen
Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In
Seeking Alpha
Thu, 04/11/13 - 11:33 am
Duchenne Muscular Dystrophy
Sarepta
GSK
eteplirsen
drisapersen
Prosensa
Glaxo's Drisapersen Data Revealed Early
TheStreet.com
Tue, 04/9/13 - 04:02 pm
GSK
drisapersen
eteplirsen
Sarepta
Duchenne Muscular Dystrophy
Sarepta-Glaxo Duchenne's Rivalry Heats Up This Week
TheStreet.com
Mon, 04/8/13 - 11:27 am
GSK
Sarepta
Duchenne Muscular Dystrophy
drisapersen
Prosensa
eteplirsen
Sarepta's Eteplirsen Boys Keep On Walking
TheStreet.com
Fri, 04/5/13 - 10:45 am
Sarepta
Duchenne Muscular Dystrophy
eteplirsen
Sarepta set to rise if seeks quick drug OK
Reuters
Mon, 03/25/13 - 11:09 am
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
next ›
last »